CY1115505T1 - COMPOSITIONS INCLUDING ANTIBODIES AGAINST CD79b CONJECTED WITH ANTI-GROWTH AGENTS OR CYTAROTOXIC FACTOR AND METHODS - Google Patents

COMPOSITIONS INCLUDING ANTIBODIES AGAINST CD79b CONJECTED WITH ANTI-GROWTH AGENTS OR CYTAROTOXIC FACTOR AND METHODS

Info

Publication number
CY1115505T1
CY1115505T1 CY20141100678T CY141100678T CY1115505T1 CY 1115505 T1 CY1115505 T1 CY 1115505T1 CY 20141100678 T CY20141100678 T CY 20141100678T CY 141100678 T CY141100678 T CY 141100678T CY 1115505 T1 CY1115505 T1 CY 1115505T1
Authority
CY
Cyprus
Prior art keywords
methods
antibodies against
cytarotoxic
conjected
factor
Prior art date
Application number
CY20141100678T
Other languages
Greek (el)
Inventor
Craig Crowley
Frederic J Desauvage
Dan L Eaton
Allen Ebens Jr
Andrew Polson
Victoria Smith
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09004091.6A external-priority patent/EP2161283B1/en
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of CY1115505T1 publication Critical patent/CY1115505T1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά συνθέσεις που περιλαμβάνουν αντισώματα εναντίον CD79b συζευγμένα με παράγοντα αναστολής αύξησης ή κυτταροτοξικό παράγοντα χρήσιμα για την θεραπευτική αγωγή αιμοποιητικού όγκου σε θηλαστικά και μεθόδους χρήσης αυτών των συνθέσεων υλικού για τον ίδιο σκοπό.The present invention relates to compositions comprising antibodies against CD79b conjugated to growth inhibitor or cytotoxic agent useful for the treatment of mammalian hematopoietic tumor and methods of using these material compositions for the same purpose.

CY20141100678T 2003-11-17 2014-08-22 COMPOSITIONS INCLUDING ANTIBODIES AGAINST CD79b CONJECTED WITH ANTI-GROWTH AGENTS OR CYTAROTOXIC FACTOR AND METHODS CY1115505T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52084203A 2003-11-17 2003-11-17
US53242603A 2003-12-24 2003-12-24
EP09004091.6A EP2161283B1 (en) 2003-11-17 2004-11-16 Compositions comprising antibodies against CD79b conjugated to a growth inhibitory agent or cytotoxic agent and methods for the treatment of tumor of hematopoietic origin

Publications (1)

Publication Number Publication Date
CY1115505T1 true CY1115505T1 (en) 2017-01-04

Family

ID=58461571

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20141100512T CY1115252T1 (en) 2003-11-17 2014-07-08 ANTISOMA VS CD22 FOR THERAPEUTIC TREATMENT OF BLOOD ORIGIN
CY20141100678T CY1115505T1 (en) 2003-11-17 2014-08-22 COMPOSITIONS INCLUDING ANTIBODIES AGAINST CD79b CONJECTED WITH ANTI-GROWTH AGENTS OR CYTAROTOXIC FACTOR AND METHODS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20141100512T CY1115252T1 (en) 2003-11-17 2014-07-08 ANTISOMA VS CD22 FOR THERAPEUTIC TREATMENT OF BLOOD ORIGIN

Country Status (1)

Country Link
CY (2) CY1115252T1 (en)

Also Published As

Publication number Publication date
CY1115252T1 (en) 2017-01-04

Similar Documents

Publication Publication Date Title
CY1121162T1 (en) M-CSF-SPECIAL MONOCLONIC ANTIBODY AND ITS USE
CY1120070T1 (en) METHOD OF THERAPEUTIC TREATMENT WITH THE USE OF ANTI-ERBB-METHYSINEOID ANTIBODY conjugates
CY1112055T1 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF LUNG TUMOR
CY1119722T1 (en) CREATION AND DESCRIPTION OF COMPLETELY HUMAN TREATMENT ANTIBODIES TAKEN INTO HUCAL GOLD SPECIAL FOR HUMAN CD38
CY1118668T1 (en) Immunoconjugates Against Folic Acid Receptors 1 and their uses
CY1117124T1 (en) HUMANIZED ANTI-β7 ANTAGONISTS AND THEIR USES
CY1110759T1 (en) SNOWLINE DIFFERENCES AND THEIR USES
CY1109888T1 (en) PRODUCTS OF 2,4-PYRIMIDINAMINE COMPOUNDS AND THEIR USES
CY1115580T1 (en) COMPOSITION AND ANTI-VIVAL ACTIVITY OF SUBSTITUTED AZAIDOLOLOXIC Piperazine Derivatives
CY1113984T1 (en) DM1 conjugate conjugate products with TRASTUZUMAB antibody, CONNECTED THROUGH NON-EXTRACTIVE CONNECTOR AND USE IN TREATMENT TREATMENT
CO5611160A2 (en) CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES
CY1112383T1 (en) Inhibitors of Protein Activation of 5-Lipoxygenase (FLAP)
CY1108344T1 (en) EXPRESSION BODIES CONTAINING THE MCMV IE2 PROPERTY
CY1112297T1 (en) Heterocyclic Suspensions of MEK and Methods of Using These
CR9763A (en) USE OF A SINGLE DOSE OF SPECIFIC UNION MOLECULES CD20
EA201201533A1 (en) PRLR-SPECIFIC ANTIBODY AND ITS APPLICATIONS
CY1112862T1 (en) UNIQUE ANTIQUES SHRAPS USEFUL AS THERAPEUTIC
CY1113094T1 (en) NAVIGATED GUIDES AGAINST NOGO
CY1108722T1 (en) Polycyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
CY1106992T1 (en) WALNUT F AND RELATED COMPOUNDS
CY1105137T1 (en) DERIVATIVES OF AMINOCYCLOHEXYL ETHERS AND THEIR USES
CY1106444T1 (en) 17B-NITRO-11B-ARYLOSTEPOIDES AND THEIR DERIVATIVES AS HORMONE AGENTS OR ANTAGONISTS
PT2161283E (en) Compositions comprising antibodies against cd79b conjugated to a growth inhibitory agent or cytotoxic agent and methods for the treatment of tumor of hematopoietic origin
DE60002855D1 (en) Haloalkoxy IMIDAZONAPHTHYRIDINE
AR063507A1 (en) DERIVATIVES OF FLUORENE, COMPOSITIONS THAT CONTAIN THEM AND USE AS ANTI-BANERIGENS